Medical Blogs

Farewell to This Blog — and Hello to NEJM Voices • March 2, 2026

After 18 years of HIV and ID Observations, this is my final post here. That’s nearly 1000 posts since March 2008 — commentary on new HIV data, debates about antibiotic duration, EMR rants, cartoon caption contests, conference highlights, pandemic pain and progress, and more than a few peeves about “quick questions.” Along the way we […] Read More

• Some Ruminations on CROI — Still the Best HIV Meeting
• Two Things Can Be True: The FDA Process Was Inconsistent, and the mRNA Vaccine Data Were Disappointing
• Sometimes You Just Need to Get Input from a Real Human Being

Developing Resident Educators • August 19, 2022 • Brandon Temte, DO

We currently find ourselves at the start of another academic year. By this time in August, many medical trainees are settling into new roles. Recently graduated medical students are getting used to hearing Dr. before their name. New senior residents who were interns a short time ago now find themselves leaders of their own teams. […] Read More

• Beginnings
• Uncertainty in Medicine — The “July Effect” and Beyond
• 10 Tips for July (and Beyond)

Podcast 301: Monkeypox — what to look for, how to treat • August 19, 2022

A VIDEO RECORDING OF THIS INTERVIEW IS AVAILABLE HERE.

This time, we look to New York for guidance on recognizing and treating monkeypox.

Dr. Eric Meyerowitz of Montefiore and Dr. Stephen Baum of Einstein will lead you through the monkeypox thicket in a 17-minute chat.

Included below is information for patients as well as links to some key articles of interest to clinicians.

LINKS:

For patients: Dr. Barry Zingman’s “Monkeypox — What you need to know”

For clinicians:

• NEJM article on monkeypox in 16 countries
• NEJM Case Records of the Mass. General Hospital on the state’s first case
• Stephen Baum’s summary of a paper in Emerging Infectious Diseases describing viral persistence on fomites

• Podcast 300: NADIM II trial offers “quite exciting” results in lung cancer
• Podcast 299: Lung cancer and atezolizumab — results from the IMpower010 trial
• Podcast 298: COPD exacerbations — 7 days of antibiotics versus 2